Ro
PrivateLast Round
Series D
Extension
Feb 15, 2022
Est. Valuation
$7B
Total Funding Raised
$1.03B
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Ro is a telehealth company offering a direct-to-consumer platform that facilitates diagnosis and convenient medication delivery, specializing in services for erectile dysfunction and smoking cessation with personalized treatment options.
Sector
Healthcare & Life Sciences
Verticals
Telemedicine, Pharma Supply Chain, D2C Brands, Subscription Commerce, Patient Engagement
Business Model
B2C
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Ro Comparables
Compare Ro with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Hims & Hers Health, Inc. | 92% | |
| Remedy Meds | 88% | |
| LifeMD Inc | 87% | |
Ro Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D Extension | Feb 15, 2022 | ||||
| Series D | Mar 23, 2021 | ||||
| Series C | Jul 27, 2020 | ||||
| Series B | Apr 16, 2019 | ||||
| Series A | Sep 18, 2018 | ||||
Seed | Nov 6, 2017 |
Key People
Founding team and executive leadership
Ro Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Torch Capital | Series D, Series A, Series C |
| Slow Ventures | Seed, Series A, Series B |
| 776 Capital | Series D |
| FirstMark Capital | Series D Extension, Series C, Series D, Series A, Series B |
| The Radcliff Companies | Series D |
| Dragoneer Investment Group | Series D |
| The Chernin Group | Series D Extension, Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 2, 2026
Partnered with Eli Lilly to launch Zepbound KwikPen nationwide.
- Apr 2, 2026
Launched the FDA-approved Zepbound KwikPen nationwide.
Ro Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Appears On
Curated lists and screens where this company is featured.
Frequently Asked Questions
Common questions about Ro's valuation, stock price, and market status.